> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Inspections Will Suffer Under FDA Cuts: Lawyers
- URL: https://www.fdaweb.com/inspections-will-suffer-under-fda-cuts-lawyers/
- Published: 2025-04-16T12:00:00.000Z
- Updated: 2026-09-14T15:09:36.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5159025

Recent FDA layoffs are raising red flags across the drug and biologic industries as experts warn that diminished inspection capacity could slow drug approvals and challenge companies’ ability to maintain GMP compliance. Pre-approval inspections are likely to suffer from staff shortages, according to a Morgan Lewis [legal update](https://www.morganlewis.com/pubs/2025/04/fda-drug-inspections-post-workforce-reductions-potential-implications-and-practical-steps-forward?ref=fdaweb.com).